Literature DB >> 18784333

Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphine.

Marilyn J Duncan1, Annadora J Bruce-Keller, Clayton Conner, Pamela E Knapp, Ruquiang Xu, Avindra Nath, Kurt F Hauser.   

Abstract

Patients with human immunodeficiency virus (HIV) infection exhibit changes in sleep patterns, motor disorders, and cognitive dysfunction; these symptoms may be secondary to circadian rhythm abnormalities. Studies in mice have shown that intracerebral injection of an HIV protein, transactivator of transcription (Tat), alters the timing of circadian rhythms in a manner similar to light. Therefore, we tested the hypothesis that chronic Tat expression alters circadian rhythms, especially their entrainment to a light-dark (LD) cycle, by using transgenic mice in which Tat expression in the brain was induced via a doxycycline (DOX)-sensitive, glial fibrillary-associated, protein-restricted promoter. Because opiate substance abuse, which shares comorbidity with HIV infection, also disrupts sleep, a final experiment assessed the effects of morphine exposure on circadian rhythms in wild-type and Tat transgenic mice. Mice housed in cages equipped with running wheels were fed chow with or without DOX. Experiment 1 revealed a small but significant (P < 0.05) difference between groups in the phase angle of entrainment and a 15% decrease in the wheel running in the DOX group (P < 0.005). During exposure to constant darkness, DOX did not alter the endogenous period length of the circadian rhythm. Experiment 2 investigated the effect of DOX on circadian rhythms in wild-type and Tat(+) mice during exposure to a normal or phase-shifted LD cycle, or morphine treatment without any change in the LD cycle. Tat induction significantly decreased wheel running but did not affect entrainment to the normal or shifted LD cycle. Morphine decreased wheel running without altering the phase angle of entrainment, and the drug's effects were independent of Tat induction. In conclusion, these findings suggest that chronic brain expression of Tat decreases locomotor activity and the amplitude of circadian rhythms, but does not affect photic entrainment or reentrainment of the murine circadian pacemaker.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784333      PMCID: PMC2584859          DOI: 10.1152/ajpregu.90496.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  44 in total

1.  Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo.

Authors:  E M Mintz; C L Marvel; C F Gillespie; K M Price; H E Albers
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Chronic morphine consumption decreases wheel running and wheel running-reinforced behavior in rats.

Authors:  M T Silva; G M Heyman
Journal:  Pharmacol Biochem Behav       Date:  2001 May-Jun       Impact factor: 3.533

3.  Resetting the biological clock: mediation of nocturnal CREB phosphorylation via light, glutamate, and nitric oxide.

Authors:  J M Ding; L E Faiman; W J Hurst; L R Kuriashkina; M U Gillette
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

4.  HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement.

Authors:  J E Bell; R P Brettle; A Chiswick; P Simmonds
Journal:  Brain       Date:  1998-11       Impact factor: 13.501

5.  Two brain nuclei controlling circadian rhythms are identified by GFAP immunoreactivity in hamsters and rats.

Authors:  L P Morin; R F Johnson; R Y Moore
Journal:  Neurosci Lett       Date:  1989-04-24       Impact factor: 3.046

6.  Involvement of hormonal circadian secretion in the growth of HIV-infected children.

Authors:  M Rondanelli; D Caselli; A Maccabruni; M Maghnie; L Bacchella; A DeStefano; S B Solerte; L Minoli; E Ferrari
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

7.  Circadian rhythm of lymphocytes and their glucocorticoid receptors in HIV-infected homosexual men.

Authors:  A H Vagnucci; A Winkelstein
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-11

8.  Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.

Authors:  Annadora J Bruce-Keller; Ashok Chauhan; Filomena O Dimayuga; Jillian Gee; Jeffrey N Keller; Avindra Nath
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

9.  Genotype-dependent behavioral sensitivity to mu vs. kappa opiate agonists. I. Acute and chronic effects on mouse locomotor activity.

Authors:  G J Gwynn; E F Domino
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

Review 10.  HIV and drug misuse in the Edinburgh cohort.

Authors:  Jeanne E Bell; J Carlos Arango; Roy Robertson; Ray P Brettle; Clifford Leen; Peter Simmonds
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

View more
  19 in total

Review 1.  Mechanisms Influencing Circadian Blood Pressure Patterns Among Individuals with HIV.

Authors:  Shia T Kent; Greer A Burkholder; Gabriel S Tajeu; E Turner Overton; Paul Muntner
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

2.  Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons.

Authors:  Sylvia Fitting; Ruqiang Xu; Cecilia Bull; Shreya K Buch; Nazira El-Hage; Avindra Nath; Pamela E Knapp; Kurt F Hauser
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

Review 3.  Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins.

Authors:  Sulie L Chang; Kaitlyn P Connaghan
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-15       Impact factor: 4.147

4.  Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats.

Authors:  Narasimha M Midde; Adrian M Gomez; Steven B Harrod; Jun Zhu
Journal:  Pharmacol Biochem Behav       Date:  2011-03-21       Impact factor: 3.533

5.  HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter.

Authors:  Sunita Gupta; Alecia G Knight; Shruti Gupta; Pamela E Knapp; Kurt F Hauser; Jeffrey N Keller; Annadora J Bruce-Keller
Journal:  Neurosci Lett       Date:  2010-09-19       Impact factor: 3.046

6.  Progressive Degeneration and Adaptive Excitability in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons Exposed to HIV-1 Tat and Morphine.

Authors:  Arianna R S Lark; Lindsay K Silva; Sara R Nass; Michael G Marone; Michael Ohene-Nyako; Therese M Ihrig; William D Marks; Viktor Yarotskyy; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  Cell Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.046

7.  HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.

Authors:  Yun Kyung Hahn; Elizabeth M Podhaizer; Kurt F Hauser; Pamela E Knapp
Journal:  Glia       Date:  2012-08-02       Impact factor: 7.452

8.  Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5.

Authors:  Jharon Silva; Oksana Polesskaya; Walter Knight; Johnny Ting Zheng; Megan Granger; Tenée Lopez; Fernando Ontiveros; Changyong Feng; Chen Yan; Karl A Kasischke; Stephen Dewhurst
Journal:  J Neuroinflammation       Date:  2012-11-20       Impact factor: 8.322

9.  HIV Tat protein affects circadian rhythmicity by interfering with the circadian system.

Authors:  T Wang; Z Jiang; W Hou; Z Li; S Cheng; L A Green; Y Wang; X Wen; L Cai; M Clauss; Z Wang
Journal:  HIV Med       Date:  2014-04-20       Impact factor: 3.180

10.  HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the prefrontal cortex, amygdala, and hypothalamic paraventricular nucleus.

Authors:  Sara R Nass; Arianna R S Lark; Yun K Hahn; Virginia D McLane; Therese M Ihrig; Liangru Contois; T Celeste Napier; Pamela E Knapp; Kurt F Hauser
Journal:  Horm Behav       Date:  2021-06-23       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.